Benjamin Halladay
Chief Financial OfficerMr. Benjamin Halladay, also known as Ben, M.B.A., is Chief Financial Officer of AchieveRx, The Quit Company (formerly known as Achieve Life Sciences, Inc.) from October 5, 2026. He was Chief Financial Officer of Esperion Therapeutics, Inc. from November 16, 2022 to September 2026. He served as Senior Director of Financial Planning and Analysis at Esperion Therapeutics, Inc. since August 2022 until November 16, 2022. From May 2017 to January 2020, Mr. Halladay was Global Finance Manager at National Oilwell Varco. From February 2016 to May 2017, Mr. Halladay was Senior Financial Analyst at BMC Software. Additionally, from June 2009 to September 2015, Mr. Halladay held multiple roles at Pfizer. He is a Certified Public Accountant. Mr. Halladay received his Bachelor’s degree in Business Administration - History from Syracuse University and a Master in Business Administration – Finance and Accounting from Fordham Gabelli School of Business.
Positions
- Company NameAchieve Life Sciences, Inc.Stock CodeQUITPositionChief Financial OfficerColleagues
- EAErik AtkissonChief Legal Officer
- LILucian IancoviciIndependent Chairman
- ADAndrew D. GoldbergCEO, President & Director
- JWJerry WanVP of Finance & Principal Accounting Officer
- KTKaitlyn TusonSenior Vice President of Marketing & Communications
- TSThomas SelligIndependent Director
- RWReid WaldmanIndependent Director
- JSJeffrey S. FarrowIndependent Director
